Completed
Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
NCT00733863
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Centre Hospitalier Universitaire Pellegrin Bordeaux, France
- Karolinska Universitetssjukhuset Huddinge Stockholm, Sweden
- NeuroPsychologieZentrum Basel, Switzerland
- Moorgreen Hospital Southampton, United Kingdom